You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 166 No. 19, October 23, 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (59)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Stroke
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

High-Sensitivity C-Reactive Protein, Lipoprotein-Associated Phospholipase A2, and Outcome After Ischemic Stroke

Mitchell S. V. Elkind, MD, MS; Wanling Tai, BS; Kristen Coates, BS; Myunghee C. Paik, PhD; Ralph L. Sacco, MD, MS

Arch Intern Med. 2006;166:2073-2080.

Background  Inflammatory markers have been associated with ischemic stroke risk and prognosis after cardiac events. Their relationship to prognosis after stroke is unsettled.

Methods  A population-based study of stroke risk factors in 467 patients with first ischemic stroke was undertaken to determine whether levels of high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2) predict risk of stroke recurrence, other vascular events, and death.

Results  Levels of Lp-PLA2 and hs-CRP were weakly correlated (r = 0.09; P = .045). High-sensitivity CRP, but not Lp-PLA2, was associated with stroke severity. After adjusting for age, sex, race and ethnicity, history of coronary artery disease, diabetes mellitus, hypertension, hyperlipidemia, atrial fibrillation, smoking, and hs-CRP level, compared with the lowest quartile of Lp-PLA2, those in the highest quartile had an increased risk of recurrent stroke (adjusted hazard ratio, 2.08; 95% confidence interval, 1.04-4.18) and of the combined outcome of recurrent stroke, MI, or vascular death (adjusted hazard ratio, 1.86; 95% confidence interval, 1.01-3.42). After adjusting for confounders, hs-CRP was not associated with risk of recurrent stroke or recurrent stroke, myocardial infarction, or vascular death but was associated with risk of death (adjusted hazard ratio, 2.11; 95% confidence interval, 1.18-3.75).

Conclusions  Inflammatory markers are associated with prognosis after first ischemic stroke and may offer complementary information. Lipoprotein-associated phospholipase A2 may be a stronger predictor of recurrent stroke risk. Levels of hs-CRP, an acute-phase reactant, increase with stroke severity and may be associated with mortality to a greater degree than recurrence.


Author Affiliations: Department of Neurology (Drs Elkind and Sacco and Ms Coates) and Sergievsky Center (Drs Elkind and Sacco), College of Physicians and Surgeons, and Divisions of Biostatistics (Mr Tai and Dr Paik) and Epidemiology (Dr Sacco), Joseph P. Mailman School of Public Health, Columbia University; and the Columbia-Presbyterian Medical Center of New York Presbyterian Hospital (Drs Elkind and Sacco and Ms Coates), New York, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke
Rost et al.
Stroke 2012;43:441-445.
ABSTRACT | FULL TEXT  

Presence of Intracranial Artery Calcification Is Associated With Mortality and Vascular Events in Patients With Ischemic Stroke After Hospital Discharge: A Cohort Study
Bugnicourt et al.
Stroke 2011;42:3447-3453.
ABSTRACT | FULL TEXT  

The Vascular Effects of Infection in Pediatric Stroke (VIPS) Study
Fullerton et al.
J Child Neurol 2011;26:1101-1110.
ABSTRACT  

Association of Circulating Inflammatory Markers With Recurrent Vascular Events After Stroke: A Prospective Cohort Study
Whiteley et al.
Stroke 2011;42:10-16.
ABSTRACT | FULL TEXT  

Lipoprotein-Associated and Secreted Phospholipases A2 in Cardiovascular Disease: Roles as Biological Effectors and Biomarkers
Mallat et al.
Circulation 2010;122:2183-2200.
FULL TEXT  

Inflammatory Mechanisms of Stroke
Elkind
Stroke 2010;41:S3-S8.
ABSTRACT | FULL TEXT  

Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease
Hatoum et al.
Am J Clin Nutr 2010;91:786-793.
ABSTRACT | FULL TEXT  

Association of C-Reactive Protein With Cognitive Impairment
Noble et al.
Arch Neurol 2010;67:87-92.
ABSTRACT | FULL TEXT  

Inflammatory Biomarkers of Vascular Risk as Correlates of Leukoariosis
Wright et al.
Stroke 2009;40:3466-3471.
ABSTRACT | FULL TEXT  

High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 Stability Before and After Stroke and Myocardial Infarction
Elkind et al.
Stroke 2009;40:3233-3237.
ABSTRACT | FULL TEXT  

Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Risk-Stratification of Patients With TIA
Cucchiara et al.
Stroke 2009;40:2332-2336.
ABSTRACT | FULL TEXT  

Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
Whiteley et al.
Stroke 2009;40:e380-e389.
ABSTRACT | FULL TEXT  

Elevated C-Reactive Protein and Long-Term Mortality After Ischaemic Stroke: Relationship With Markers of Endothelial Cell and Platelet Activation
Shantikumar et al.
Stroke 2009;40:977-979.
ABSTRACT | FULL TEXT  

Lipoprotein-Associated Phospholipase A2 and High-Sensitivity C-Reactive Protein Improve the Stratification of Ischemic Stroke Risk in the Atherosclerosis Risk in Communities (ARIC) Study
Nambi et al.
Stroke 2009;40:376-381.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.